Evidence map›Paper›PMID 42707337›Full record

ReviewFrontiers in cell and developmental biology2026

Beyond bacterial dysbiosis: the emerging role of gut bacteriophages in type 2 diabetes.

Yimei Tao, Zhaoxiang Wang, Shao Zhong

Abstract readReview
In one paragraph

Review in Frontiers in cell and developmental biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yimei TaoGusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Kunshan, China.
Zhaoxiang WangDepartment of Endocrinology, Affiliated Kunshan Hospital of Jiangsu University, Kunshan, China.
Shao ZhongGusu School, Nanjing Medical University, The First People's Hospital of Kunshan, Kunshan, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bacteriophages, the viruses that infect gut bacteria, are now seen as active members of the intestinal ecosystem rather than passive observers. In type 2 diabetes mellitus (T2DM), growing evidence suggests that the gut phage community changes in several important ways. People with T2DM often have lower phage diversity, more temperate phages, and shifts in bacterial hosts. These changes may spread through the microbial network, affecting gene exchange, bacterial metabolism, and immune activity. Through these pathways, phages may contribute to microbial and immune alterations associated with insulin resistance and the chronic inflammation that characterizes T2DM, even though direct proof of causality is still missing. Diet and metabolic stress also influence how phages behave, including their replication cycles and host preferences. This means that environmental factors can constantly reshape the gut virome and, in turn, affect metabolic health. Recognizing this link moves the focus beyond bacterial imbalance to a broader concept of phage-mediated metabolic dysregulation, in which viruses may represent underrecognized contributors to energy balance and inflammation. Understanding these interactions may reveal new microbial targets and guide the development of phage-based or microbiome-based approaches for the prevention and treatment of T2DM.

Indexed as

bacteriophagegut viromemetabolic inflammationmicrobial metabolismphage therapytype 2 diabetes mellitus

Identifiers

PMID42707337
PMCPMC13547728

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.